MESA, AZ--(Marketwire - March 16, 2012) - Ulthera
, Inc. -- a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology -- today announced that it is now registered in Mexico to market and distribute its patented medical device, the Ulthera System.
In Mexico, the System -- which combines time-honored ultrasound imaging with focused ultrasound therapy in a treatment known as Ultherapy -- is "prescribed to produce stimulation in tissues to raise the temperature in a localized manner for aesthetic, non-invasive use."(1) The procedure encourages the natural formation of collagen and elastin in the skin, giving it the ability to lift tissue. In Mexico, the technology will be used specifically to lift tissue on the face, neck, décolleté, knees and arms.
"Clearance of the Ulthera System in Mexico -- and more than 35 other countries -- is a testament to the value that markets around the world place in our platform technology and its use for multiple non-invasive applications," said Matthew Likens, president and CEO of Ulthera. "We anticipate a high adoption rate of the System by Mexican medical professionals due to the growing demand for safe and effective non-surgical solutions to treat the aging skin."
Arfamex, a leading distributor of ophthalmology and dermatology devices in Mexico, will be the exclusive distributor of the Ulthera System in this important new market.
"The demand for the Ulthera System in Mexico is already high, so we have been very eager to receive country clearance to sell it," said Antonio Rodriguez, sales director for Arfamex. "We are honored to distribute the System and to partner with such an innovative and steadfast company pioneering ultrasound for non-invasive cosmetic procedures."
"Arfamex was the clear choice as a Mexican partner to maintain the high customer service standard for which our brand is known in the U.S. and other countries," said Likens. "Having an established and respected Mexican partner on board will help Ulthera rapidly broaden the reach of our technology."
The Ulthera System is cleared by the U.S. FDA for use in a non-invasive treatment of the face to lift the eyebrow to achieve a desired aesthetic effect.
1 - Verbiage taken directly from Mexico's Ministry of Health registration document. Public Health Registration No.0328E2012 SSA; Application No. 113300401E0574.
Ulthera®, Inc. is a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® -- the procedure enabled by the System -- is a non-invasive treatment of the face to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ulthera.com.
Arfamex S.A de C.V. is a Mexican company, establish in 1989. Since 1993, the company has been a Mexican leader for the sales of medical equipment in the fields of dermatology, plastic surgery and ophthalmology. Arfamex is a private company located in Mexico City with a national presence. For more information, visit www.arfamex.com.